Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantation

Annals of the New York Academy of Sciences

Volumn 872, Issue , 1999, Pages 363-371

  Brugger, W ^a   Brossart, P ^a   Scheding, S ^a   Stuhler, G ^a   Heinrich, K ^a   Reichardt, V ^a   Grunebach F ^a   Buhring H J ^a   Kanz, L ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD34 ANTIGEN; PEPTIDE; PROTEIN;

ADVANCED CANCER; ANTIGEN PRESENTING CELL; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG MEGADOSE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; IMMUNOTHERAPY; LEUKEMIA; MINIMAL RESIDUAL DISEASE; MONOCYTE; ONCOGENE NEU; OVARY CANCER; PERIPHERAL BLOOD STEM CELL; SOLID TUMOR; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; VACCINATION;

EID: 0033041840     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08480.x     Document Type: Conference Paper

References (22)

1. PARDOLL, D.M. 1998. Cancer vaccines. Nat. Med. 4: 525-531.
2. STEINMANN, A.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
3. CELLA, M., F. SALLUSTO & A. LANZAVECCHIA. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin Immunol. 9: 10-16.
4. CAUX, C., C. DEZUTTER-DEMBUYANT, D. SCHMITT & J. BANCHEREAU. 1992. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 55: 258-261.
5. + bone marrow progenitors that are expanded by c-kit ligand and yield pure dendritic cell colonies in the presence of GM-CSF and TNFa. J. Exp. Med. 182: 1111-1120.
6. + hematopoietic progenitor cells in cancer patients. Eur. J. Immunol. 26: 595-560.
7. + hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J. Exp. Med. 185: 341-349.
8. KANZ, L & W. BRUGGER. 1998. Mobilization and ex vivo manipulation of peripheral blood progenitor cells for support of high-dose cancer therapy. In Bone Marrow Transplantation. 2nd edit. E.D. Thomas, K.G. Blume & S.J. Forman, Eds.: 455-468. Blackwell Science, Inc. Boston, MA.
9. SALLUSTO, F. & A. LANZAVECCHIA. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by GM-CSF plus IL-4 and down regulated by TNFa. J. Exp. Med. 179: 1109-1118.
10. + dendritic cells. Proc. Natl. Acad. Sci. USA 93: 2588-2592.
11. BROSSART, P., G. STUHLER, T. FLAD et al. 1998. HER-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and recognized by in vitro-induced specific cytotoxic T-lymphocytes. Cancer Res. 58: 732-736.
12. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicine. Blood 84: 1421-1426.
13. BROSSART, P., F. GRÜNEBACH, G. STUHLER et al. 1998. Generation of functional dendritic cells from adherent peripheral blood mononuclear cells by CD40 ligation in the absence of GM-CSF. Blood 92: 4238-4247.
14. + hemopoietic progenitor cells. J. Immunol. 157: 1499-1507.
15. + PBPC in serum-free medium [abstract]. Blood 90: 478a.
16. BENNETT, S.R.M., F. R. CARBONNE, F. KARAMALIS et al. 1998. Help from cytotxic T-cell responses is mediated by CD40 signalling. Nature 393: 478-480.
17. SCHOENBERGER, S.P., R.E.M. TOES, E.J.H. VAN DER VOORT et al. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
18. + T-helper and a T-killer cell. Nature 393: 474-478.
19. PIEPER, M., P.S. GOEDEBEBUURE, D.C. LINEHAN et al. 1997. The Her-2/neu derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes. Eur. J. Immunol. 27: 1115-1123.
20. HSU, F.J., C. BENIKE, F. FAGNONI et al. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2: 52-58.
21. REICHARDT, V., C. OKADA, C. BENIKE et al. 1996. Idiotypic vaccination using dendritic cells for multiple myeloma patients after autologous peripheral blood stem cell transplantation [abstract]. Blood 88: 481a.
22. NESTLE, F.O., S. ALIJAGIC, M. GILLIET et al. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells, Nat. Med. 4: 328-332.